139 related articles for article (PubMed ID: 7455968)
1. Anticoagulant and antithrombotic action of novel specific inhibitors of thrombin.
Hauptmann J; Kaiser B; Markwardt F; Nowak G
Thromb Haemost; 1980 Jun; 43(2):118-23. PubMed ID: 7455968
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of benzamidine-type thrombin inhibitors.
Hauptmann J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):89-97. PubMed ID: 6177614
[TBL] [Abstract][Full Text] [Related]
3. Anticoagulant and antithrombotic action of the synthetic thrombin inhibitor D-phenylalanyl-L-prolyl-L-arginine nitrile.
Kaiser B; Richter M; Hauptmann J; Markwardt F
Pharmazie; 1991 Feb; 46(2):128-31. PubMed ID: 1852761
[TBL] [Abstract][Full Text] [Related]
4. [Synthetic inhibitors of serine proteinases. 32. Inhibition of trypsin, plasmin and thrombin by amides of N-alpha-substituted 4-amidinophenylalanine. Effect of various amino acids and blocking groups of the n-alpha residue on inhibitory activity].
Stürzebecher J; Markwardt F; Walsmann P; Voigt B; Wagner G
Pharmazie; 1987 Feb; 42(2):114-6. PubMed ID: 2955429
[TBL] [Abstract][Full Text] [Related]
5. [Synthetic inhibitors of serine proteinases. Part 25: Inhibition of trypsin, plasmin and thrombin by amides of N alpha-substituted amidinophenylalanines and 3-amidinophenyl-3-aminopropionic acids (author's transl)].
Stürzebecher J; Horn H; Markwardt F; Wagner G; Walsmann P
Pharmazie; 1981 Sep; 36(9):639-41. PubMed ID: 6458047
[TBL] [Abstract][Full Text] [Related]
6. Efficacious and orally bioavailable thrombin inhibitors based on a 2,5-thienylamidine at the P1 position: discovery of N-carboxymethyl-d-diphenylalanyl-l-prolyl[(5-amidino-2-thienyl)methyl]amide.
Lee K; Park CW; Jung WH; Park HD; Lee SH; Chung KH; Park SK; Kwon OH; Kang M; Park DH; Lee SK; Kim EE; Yoon SK; Kim A
J Med Chem; 2003 Aug; 46(17):3612-22. PubMed ID: 12904065
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the anticoagulant and antithrombotic effects of synthetic thrombin and factor Xa inhibitors.
Hauptmann J; Kaiser B; Nowak G; Stürzebecher J; Markwardt F
Thromb Haemost; 1990 Apr; 63(2):220-3. PubMed ID: 2363124
[TBL] [Abstract][Full Text] [Related]
8. In-depth study of tripeptide-based alpha-ketoheterocycles as inhibitors of thrombin. Effective utilization of the S1' subsite and its implications to structure-based drug design.
Costanzo MJ; Almond HR; Hecker LR; Schott MR; Yabut SC; Zhang HC; Andrade-Gordon P; Corcoran TW; Giardino EC; Kauffman JA; Lewis JM; de Garavilla L; Haertlein BJ; Maryanoff BE
J Med Chem; 2005 Mar; 48(6):1984-2008. PubMed ID: 15771442
[TBL] [Abstract][Full Text] [Related]
9. N alpha-arylsulfonyl-omega-amidinophenyl-alpha-aminoalkyl-carboxylic acid amides as specific thrombin inhibitors.
Stürzebecher J
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):83-8. PubMed ID: 6177613
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic potential of new direct thrombin inhibitors built on the azaphenylalanine scaffold in two rat venous thrombosis models.
Peternel L; Stegnar M; Drevensek G; Budihna MV; Bozic M; Zega A; Stalc A; Cerne M; Urleb U
Thromb Haemost; 2005 Mar; 93(3):437-42. PubMed ID: 15735792
[TBL] [Abstract][Full Text] [Related]
11. [Synthesis of N-alpha-(arylsulfonyl-L-prolyl)- and N alpha-(benzyloxycarbonyl-L-prolyl)-D,L-4-amidinophenylalanine amides as inhibitors of thrombin].
Voigt B; Wagner G
Pharmazie; 1986 Apr; 41(4):233-5. PubMed ID: 3725864
[TBL] [Abstract][Full Text] [Related]
12. Comparative study on the antithrombotic effects of a synthetic thrombin inhibitor and of heparin in animal models.
Hauptmann J; Barth A; Schönberger FP; Markwardt F
Biomed Biochim Acta; 1983; 42(7-8):959-65. PubMed ID: 6651812
[TBL] [Abstract][Full Text] [Related]
13. Incorporation of neutral C-terminal residues in 3-amidinophenylalanine-derived matriptase inhibitors.
Schweinitz A; Dönnecke D; Ludwig A; Steinmetzer P; Schulze A; Kotthaus J; Wein S; Clement B; Steinmetzer T
Bioorg Med Chem Lett; 2009 Apr; 19(7):1960-5. PubMed ID: 19250826
[TBL] [Abstract][Full Text] [Related]
14. [Synthetic inhibitors of serine proteinases. 34. The effect of modification of the amidino function of N-alpha-substituted 4-amidinophenylalanine amides on inhibitory activity].
Stürzebecher J; Horn H; Walsmann P; Voigt B; Markwardt F; Wagner G
Pharmazie; 1988 Nov; 43(11):782-3. PubMed ID: 3247368
[TBL] [Abstract][Full Text] [Related]
15. [The pharmacodynamics of synthetic thrombin inhibitors of the basic type substituted n-alpha arylsulfonylated phenylalanine amide].
Kaiser B; Hauptmann J; Markwardt F
Pharmazie; 1987 Feb; 42(2):119-21. PubMed ID: 3602050
[TBL] [Abstract][Full Text] [Related]
16. [Synthetic inhibitors of serine proteinases. 28. The inhibitory effect of esters of N-alpha-arylsulfonyl-4-amidinophenylalanine against trypsin, plasmin and thrombin].
Walsmann P; Horn H; Markwardt F; Stürzebecher J; Wagner G
Pharmazie; 1982 Jun; 37(6):457. PubMed ID: 6214801
[No Abstract] [Full Text] [Related]
17. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
Glusa E; Hoffmann A; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
[TBL] [Abstract][Full Text] [Related]
18. Potent noncovalent thrombin inhibitors that utilize the unique amino acid D-dicyclohexylalanine in the P3 position. Implications on oral bioavailability and antithrombotic efficacy.
Tucker TJ; Lumma WC; Lewis SD; Gardell SJ; Lucas BJ; Baskin EP; Woltmann R; Lynch JJ; Lyle EA; Appleby SD; Chen IW; Dancheck KB; Vacca JP
J Med Chem; 1997 May; 40(11):1565-9. PubMed ID: 9171866
[TBL] [Abstract][Full Text] [Related]
19. [Synthesis of N alpha-(arylsulfonylglycylglycyl)-4-amidinophenylalanine amides as thrombin inhibitors].
Voigt B; Wagner G
Pharmazie; 1984 Jun; 39(6):379-81. PubMed ID: 6483943
[TBL] [Abstract][Full Text] [Related]
20. [Synthesis of N-alpha-benzyloxycarbonyl-4-amidinophenylalanine amides as thrombin inhibitors].
Voigt B; Wagner G
Pharmazie; 1985 May; 40(5):305-6. PubMed ID: 4034633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
